News - Page 223 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

Post published:January 6, 2021
Post category:Press Release

Read more about the article Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research

Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research

Post published:January 6, 2021
Post category:Press Release

Read more about the article MEC announces letter of intent to acquire Albert Labs, a European psychedelic drug researcher & developer

MEC announces letter of intent to acquire Albert Labs, a European psychedelic drug researcher & developer

Post published:January 5, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Closing of Bought Deal Financing

Field Trip Health Ltd. Announces Closing of Bought Deal Financing

Post published:January 5, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Post published:January 5, 2021
Post category:Press Release

Read more about the article MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

Post published:January 4, 2021
Post category:Press Release

Read more about the article Empower Clinics Closes Agreement to Acquire Canadian Clinics, Announces Significant Discussions with Nationwide Rollout Partners and Proceeds From Exercise of Warrants Now Exceeding $6,900,000 to Conclude its Most Successful Year Ever

Empower Clinics Closes Agreement to Acquire Canadian Clinics, Announces Significant Discussions with Nationwide Rollout Partners and Proceeds From Exercise of Warrants Now Exceeding $6,900,000 to Conclude its Most Successful Year Ever

Post published:January 4, 2021
Post category:Press Release

Read more about the article NeonMind Commences Trading Under CSE Ticker Symbol “NEON”

NeonMind Commences Trading Under CSE Ticker Symbol “NEON”

Post published:January 4, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD

BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD

Post published:January 4, 2021
Post category:Press Release

Read more about the article Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange

Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange

Post published:January 4, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.